Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
06.02.2026
Pharmasyntez to Establish R&D Center in Skolkovo for Development of Life-Saving Medicines
Latest news
27.03.2026
Mikhail Kvasnikov, Pharmasyntez-Nord CEO, Named Among Top 3 Pharma Executives in St. Petersburg
06.03.2026
Pharmasyntez Group Serves as Industry Partner for Region's Largest New School: a New Educational Center Commemorating the 80th Anniversary of the Great Victory is Nearing its Grand Opening in Irkutsk
18.02.2026
Pharmasyntez as a Model for Reform: Russian Federal Tax Service Delegation Studies Human-Centric Approaches in Irkutsk
11.02.2026
Pharmasyntez and Cuba's CNEURO Forge Strategic Alliance to Develop Innovative Alzheimer's Treatment
About
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
Pharmasyntez-Medtech
BratskChemSyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez
Pharmasyntez-Medtech